Charles Schwab Investment Management Inc Adaptive Biotechnologies Corp Transaction History
Charles Schwab Investment Management Inc
- $521 Billion
- Q1 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 922,742 shares of ADPT stock, worth $10.9 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
922,742
Previous 956,574
3.54%
Holding current value
$10.9 Million
Previous $5.74 Million
19.45%
% of portfolio
0.0%
Previous 0.0%
Shares
23 transactions
Others Institutions Holding ADPT
# of Institutions
246Shares Held
156MCall Options Held
44.3KPut Options Held
47.8K-
Viking Global Investors LP30MShares$354 Million0.74% of portfolio
-
Rubric Capital Management LP New York, NY13.1MShares$155 Million2.79% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$138 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.1MShares$131 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.73MShares$91.2 Million0.62% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.69B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...